MUMBAI, India, May 29 -- Intellectual Property India has published a patent application (202621029754 A) filed by Devliya Bhargav A; Bimalkumar Patel R; Hitesh D. Patel; Chauhan Shreya J; Milan Thakar; and Guarang Sindhav, Ahmedabad, Gujarat, on March 12, for 'a novel synthesis of 2-(imidazolyl-thio)-n-arylacetamide derivatives.'
Inventor(s) include Devliya Bhargav A; Bimalkumar Patel R; Hitesh D. Patel; Chauhan Shreya J; Milan Thakar; Guarang Sindhav; Jaykumar Nagapara; and Pooja Trivedi.
The application for the patent was published on May 29, under issue no. 22/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a novel one-pot synthesis of 2-(imidazolyl-thio)-n-arylacetamide derivatives of formula I. More particularly, the present invention also relates to a novel one-pot synthesis of 2-(imidazolyl-thio)-n-arylacetamide derivatives of formula I. The invention further pertains to the resulting hybrids were conceived to modulate enzymatic targets involved in microbial folate biosynthesis, particularly dihydropteroate synthase (DHPS), thereby offering a dual mode of action that combines interference with essential metabolic pathways and broad-spectrum antimicrobial activity."
Disclaimer: Curated by HT Syndication.
